Hostname: page-component-586b7cd67f-gb8f7 Total loading time: 0 Render date: 2024-11-23T22:51:38.526Z Has data issue: false hasContentIssue false
  • English
  • Français

Nutrient and toxin interactions in neurodegenerative disease

Published online by Cambridge University Press:  28 February 2007

Peter H. Evans
Peter H. Evans*
Affiliation:
MRC Dunn Nutrition Unit, Milton Road, Cambridge CB4 1XJ
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Symposium on ‘Nutrition of the Brain’
Information
Proceedings of the Nutrition Society , Volume 53 , Issue 2 , July 1994 , pp. 431 - 442
Copyright
Copyright © The Nutrition Society 1994

References

Adams, J. D. & Odunze, I. N. (1991). Oxygen free radicals and Parkinson's disease. Free Radical Biology & Medicine 10, 161–169.CrossRefGoogle ScholarPubMed
Barker, D. J. P., Osmand, C., Winter, P. D., Margetts, B. & Simmonds, S. J. (1989). Weight in infancy and death from ischaemic heart disease. Lancet ii, 577–580.CrossRefGoogle Scholar
Behl, C., Davis, J., Cole, G. M. & Schubert, D. (1992). Vitamin E protects nerve cells from amyloid β protein toxicity. Biochemical and Biophysical Research Communications 186, 944–950.CrossRefGoogle ScholarPubMed
Benton, D. (1992). Vitamin-mineral supplements and intelligence. Proceedings of the Nutrition Society 51, 295–302.CrossRefGoogle ScholarPubMed
Benzi, G., Pastoris, O., Marsatico, F. & Villa, R. F. (1989). Age-related effect induced by oxidative stress on the cerebral glutathione system. Neurochemical Research 14, 473–481.CrossRefGoogle ScholarPubMed
Binkova, B., Erin, A. N., Sram, R. J. & Topinka, J. (1990). Lipid peroxidation-induced changes in physical properties of annular lipids in rat brain synaptosomal membranes. General Physiology and Biophysics 9, 311–318.Google ScholarPubMed
Birchall, J. D. (1993). Dissolved silica and bioavailability of aluminium. Lancet 342, 299.CrossRefGoogle ScholarPubMed
Boje, K. M. & Arora, P. K. (1992). Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death. Brain Research 587, 250–256.CrossRefGoogle ScholarPubMed
Burns, A., Gillett, D. S., Jacoby, R. & Mibashan, R. S. (1986). Vitamin B12 absorption in psychogeriatric patients. International Journal of Geriatric Psychiatry 1, 141–143.Google Scholar
Burns, A., Marsh, A. & Bender, D. A. (1989). A trial of vitamin supplementation in senile dementia. International Journal of Geriatric Psychiatry 4, 333–338.CrossRefGoogle Scholar
Calne, D. B., McGeer, E., Eisen, A. & Spencer, P. (1986). Alzheimer's disease, Parkinson's disease and motorneurone disease: abiotropic interaction between ageing and environment Lancet ii, 1067–1070.CrossRefGoogle Scholar
Campbell, D., Bunker, V. W., Thomas, A. J. & Clayton, B. E. (1989). Selenium and vitamin E status of healthy and institutionalized elderly subjects: analysis of plasma, erythrocytes and platelets. British Journal of Nutrition 62, 221–227.CrossRefGoogle ScholarPubMed
Candy, J. M., Klinowski, J., Perry, R. H., Perry, E. K., Fairbairn, A., Oakley, A. E., Carpenter, T. A., Atack, J. R., Blessed, G. & Edwardson, J. A. (1986). Aluminosilicates and senile plaque formation in Alzheimer's disease. Lancet i, 354–357.CrossRefGoogle Scholar
Carlisle, E. M. & Curran, M. J. (1987). Effect of dietary silicon and aluminium on silicon and aluminium levels in rat brain. Alzheimer Disease and Associated Disorders 1, 83–89.Google ScholarPubMed
Clausen, J., Nielson, S. A. & Kristensen, M. (1989). Biochemical and clinical effects of an antioxidative supplementation of geriatric patients. A double blind study. Biological Trace Element Research 20, 135–151.CrossRefGoogle ScholarPubMed
Connor, J. R., Menzies, S. L., St Martin, S. M. & Mufson, E. J. (1992). A histochemical study of iron, transferrin, and ferritin in Alzheimer's disease brains. Journal of Neuroscience Research 31, 75–83.Google Scholar
Constantinidis, J. (1992). Treatment of Alzheimer's disease by zinc compounds. Drug Development Research 27, 1–14.CrossRefGoogle Scholar
Corrigan, F. M., Van Rhijn, A. G., Ijomah, G., McIntyre, F., Skinner, E. R., Horrobin, D. F. & Ward, N. I. (1991). Tin and fatty acids in dementia. Prostaglandins, Leukotrienes and Essential Fatty Acids 43, 229–238.CrossRefGoogle ScholarPubMed
Couzy, F., Keen, C., Gershwin, M. E. & Mareschi, J. P. (1993). Nutritional implications of the interactions between minerals. Progress in Food and Nutrition Science 17, 65–87.Google ScholarPubMed
Coyle, J. T. & Puttfarken, P. (1993). Oxidative stress, glutamate, and neurodegenerative disorders. Science 262, 689–695.CrossRefGoogle ScholarPubMed
Crary, E. J., Smyrna, G. & McCarty, M. F. (1984). Potential clinical applications for high-dose nutritional antioxidants. Medical Hypothesis 13, 77–98.CrossRefGoogle ScholarPubMed
Davis, J. B., McMurray, H. F. & Schubert, D. (1992). The amyloid beta-protein of Alzheimer's disease is chemotactic for mononuclear phagocytes. Biochemical and Biophysical Research Communications 189, 1096–1100.CrossRefGoogle ScholarPubMed
Deng, H.-X., Hentati, A., Tainer, J. A., Iqbal, Z., Cayabyab, A., Hung, W. Y., Getzoff, E. D., Hu, P., Herzfeldt, B., Roos, R. P., Warner, C., Deng, . G., Soriano, E., Smyth, C., Parge, H. E., Ahmed, A., Roses, A. D., Hallewell, R. A., Pericak-Vance, M. A. & Siddique, T. (1993). Amyotrophic lateral sclerosis and structural defects in Cu, Zn superoxide dismutase. Science 261, 1047–1051.CrossRefGoogle ScholarPubMed
Domingo, J. L., Gomez, M., Llobet, J. M. & Corbella, J. (1991). Influence of some dietary constituents on aluminum absorption and retention in rats. Kidney International 39, 598–601.CrossRefGoogle ScholarPubMed
Dowson, J. H. (1989). Neuronal lipopigment: a marker for cognitive impairment and long-term effects of psychotropic drugs. British Journal of Psychiatry 155, 1–11.Google ScholarPubMed
Dreosti, I. E. (1989). Neurobiology of zinc. In Zinc in Human Biology. pp. 235–247 [Mills, C. F., editor]. London: Springer Verlag.CrossRefGoogle Scholar
Dyrks, T., Dyrks, E., Hartmann, T., Masters, C. & Beyreuther, K. (1992). Amyloidogenicity of βA4 and βA4-bearing amyloid protein precursor fragments by metal-catalysed oxidation. Journal of Biological Chemistry 267, 18210–18217.CrossRefGoogle Scholar
Edwardson, J. A., Moore, P. B., Ferrier, I. N., Lilley, J. S., Newton, G. W. A., Barker, J., Templar, J. & Day, J. P. (1993). Effect of silicon on gastrointestinal absorption of aluminium. Lancet 342, 211–212.Google ScholarPubMed
Evans, P. H. (1993). Free radicals in brain metabolism and pathology. British Medical Bulletin 49, 577–587.CrossRefGoogle ScholarPubMed
Evans, P. H., Klinowski, J. & Yano, E. (1991). Cephaloconiosis: a free radical perspective on the proposed particulate-induced etiopathogenesis of Alzheimer's dementia and related disorders. Medical Hypothesis 34, 209–219.CrossRefGoogle ScholarPubMed
Evans, P. H., Peterhans, E., Bürge, T. & Klinowski, J. (1992 a). Aluminosilicate-induced free radical generation by murine brain glial cells in vitro: potential significance in the etiopathogenesis of Alzheimer's dementia. Dementia 3, 1–6.Google Scholar
Evans, P. H., Yano, E., Klinowski, J. & Peterhans, E. (1992 b). Oxidative damage in Alzheimer's dementia, and the potential etiopathogenic role of aluminosilicates, microglia and micronutrient interactions. In Free Radicals and Aging, pp. 178–189 [Emerit, I. and Chance, B., editors]. Basel: Birkhäuser.Google Scholar
Fahal, I. H., Yaqoob, M., Williams, P. S., Ahmad, R., Roberts, N. B. & Bell, G. M. (1994). Does silicon protect against aluminium in dialysis patients? Lancet 343, 122–123.CrossRefGoogle ScholarPubMed
Fahn, S. (1992). A pilot trial of high-dose alpha-tocopherol and ascorbate in early Parkinson's disease. Annals of Neurology 32, S128–S132.CrossRefGoogle ScholarPubMed
Florence, T. M. & Stauber, J. L. (1989). Manganese catalysis of dopamine oxidation. The Science of the Total Environment 78, 233–240.CrossRefGoogle ScholarPubMed
Ghersi-Egea, J.-F., Livertoux, M.-H., Minn, A., Perrin, R. & Siest, G. (1991). Enzyme mediated superoxide radical formation initiated by exogenous molecules in rat brain preparations. Toxicology and Applied Pharmacology 110, 107–117.CrossRefGoogle ScholarPubMed
Götz, M. E., Freyberger, A., Hauer, E., Burger, R., Sofic, E., Gsell, W., Heckers, S., Jellinger, K., Hebenstreit, G., Frölich, L., Beckmann, H. & Reiderer, P. (1992). Susceptibility of brains from patients with Alzheimer's disease to oxygen-stimulated lipid peroxidation and differential scanning calorimetry. Dementia 3, 213–222.Google Scholar
Greenwood, J. (1991). Mechanisms of blood-brain barrier breakdown. Neuroradiology 33, 95–100.CrossRefGoogle ScholarPubMed
Grünewald, R. A. (1993). Ascorbic acid in the brain. Brain Research Reviews 18, 123–133.CrossRefGoogle ScholarPubMed
Guilarte, T. R. (1993). Vitamin B6 and cognitive development: recent research findings from human and animal studies. Nutrition Reviews 51, 193–198.Google ScholarPubMed
Gutteridge, J. M. C. (1992). Iron and oxygen radicals in the brain. Annals of Neurology 32, S16–S21.CrossRefGoogle Scholar
Halliwell, B. (1992). Reactive oxygen species and the central nervous system. Journal of Neurochemistry 59, 1609–1623.CrossRefGoogle ScholarPubMed
Harman, D. (1984). Free radical theory of aging: the ‘free radical’ diseases. Age 7, 111–131.CrossRefGoogle Scholar
Harman, D., Eddy, D. E. & Noffsinger, J. (1976). Free radical theory of aging: inhibition of amyloidosis in mice by antioxidants; possible mechanism. Journal of the American Geriatrics Society 24, 203–210.Google ScholarPubMed
Haurani, F. I. (1989). The effects of free radicals on cobalamin and iron. Free Radical Research Communications 7, 241–243.CrossRefGoogle ScholarPubMed
Henderson, A. S., Jorm, A. F., Korten, A. E., Creasey, H., McCusker, E., Broe, G. A., Longley, W. & Anthony, J. C. (1992). Environmental risk factors for Alzheimer's disease: their relationship to age of onset and to familial or sporadic types. Psychological Medicine 22, 429–436.CrossRefGoogle ScholarPubMed
Hershey, L. A., Hershey, C. O. & Varnes, A. W. (1984). CSF silicon in dementia: a prospective study. Neurology 34, 1197–1201.CrossRefGoogle ScholarPubMed
Hillered, L. & Ernster, L. (1983). Respiratory activity of isolated rat brain mitochondria following in vitro exposure to oxygen radicals. Journal of Cerebral Blood Flow and Metabolism 3, 207–214.CrossRefGoogle ScholarPubMed
Hirsch, E. C., Brandel, J.-P., Galle, P., Javoy-Agid, F. & Agid, Y. (1991). Iron and aluminium increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis. Journal of Neurochemistry 56, 446–451.CrossRefGoogle ScholarPubMed
Keaney, J. F., Gaziano, J. M., Xu, A., Frei, B., Curran-Celentano, J., Shwaery, G. T., Loscalzo, J. & Vita, J. A. (1993). Dietary antioxidants preserve endothelium-dependent vessel relaxation in cholesterol-fed rabbits. Proceedings of National Academy of Sciences, USA 90, 11880–11884.CrossRefGoogle ScholarPubMed
Kedziora, J. & Bartosz, G. (1988). Down's syndrome: a pathology involving the lack of balance of reactive oxygen species. Free Radical Biology & Medicine 4, 317–330.CrossRefGoogle ScholarPubMed
Kohen, R., Yamamoto, Y., Cundy, K. C. & Ames, B. N. (1988). Antioxidant activity of carnosine, homocarnosine, and anserine present in muscle and brain. Proceedings of National Academy of Sciences, USA 85, 3175–3179.CrossRefGoogle ScholarPubMed
Landfield, P. W. & Morgan, G. A. (1984). Chronically elevating plasma Mg2+ improves hippocampal frequency potentiation and reversal learning in aged and young rats. Brain Research 322, 167–171.CrossRefGoogle ScholarPubMed
Landsberg, J. P., McDonald, B. & Watt, F. (1992). Absence of aluminium in neuritic plaque cores in Alzheimer's disease. Nature 360, 65–68.CrossRefGoogle ScholarPubMed
LeBel, C. P. & Bondy, S. C. (1991). Oxygen radicals: common mediators of neurotoxicity. Neurotoxicology and Teratology 13, 341–346.CrossRefGoogle ScholarPubMed
Levitt, A. J. & Karlinsky, H. (1992). Folate, vitamin B12 and cognitive impairment in patients with Alzheimer's disease. Acta Psychiatrica Scandinavica 86, 301–305.CrossRefGoogle ScholarPubMed
Lindeman, R. D., Clark, M. L. & Colmore, J. P. (1971). Influence of age and sex on plasma and red-cell zinc concentrations. Journal of Gerontology 26, 358–363.CrossRefGoogle ScholarPubMed
Lipton, S. A., Choi, Y.-B., Pan, Z.-H., Lei, S. Z., Chen, H.-S.V., Sucher, N. J., Loscalzo, J., Singel, D. J. & Stamler, J. S. (1993). A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 364, 626–632.Google ScholarPubMed
Lovell, M. A., Ehmann, W. D. & Markesbery, W. R. (1993). Laser microprobe analysis of brain aluminum in Alzheimer's disease. Annals of Neurology 33, 36–42.CrossRefGoogle ScholarPubMed
Lucas, A. (1993). Influence of neonatal nutrition on long-term outcome. In Nutrition and the Low Birthweight Infant, pp. 183–196 [Salle, B. L. and Swyer, P. R., editors]. New York: Raven Press.Google Scholar
McGeer, P. L., Kawamata, T., Walker, D. G., Akiyama, H., Tooyama, I. & McGeer, E. G. (1993). Microglia in degenerative neurological disease. Glia 7, 84–92.CrossRefGoogle ScholarPubMed
McLachlan, D. R. C., Dalton, A. J., Kruck, T. P. A., Bell, M. Y., Smith, W. L., Kalow, W. & Andrews, D. F. (1991). Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet 337, 1304–1308.CrossRefGoogle Scholar
Mann, D. M. A., Tucker, C. M. & Yates, P. O. (1988). Alzheimer's disease: an olfactory connection? Mechanisms of Ageing and Development 42, 1–15.Google ScholarPubMed
Mann, D. M. A., Younis, N., Jones, D. & Stoddart, R. W. (1992). The time course of pathological events in Down's syndrome with special reference to the involvement of microglial cells and deposits of β/A4. Neurodegeneration 1, 201–215.Google Scholar
Maragos, W. F., Greenamyre, J. T., Penney, J. B. & Young, A. B. (1987). Glutamate dysfunction in Alzheimer's disease: an hypothesis. Trends in Neurosciences 10, 65–68.CrossRefGoogle Scholar
Martin, J. B. (1993). Molecular genetics of neurological diseases. Science 262, 674–676.CrossRefGoogle ScholarPubMed
Martyn, C. N. (1992). The epidemiology of Alzheimer's disease in relation to aluminium. In Aluminium in Biology and Medicine, pp. 69–86 [Chadwick, D. J. and Whelan, J., editors]. Chichester: Wiley.Google Scholar
Meldrum, B. (1993). Amino acids as dietary excitotoxins: a contribution to understanding neurodegenerative disorders. Brain Research Reviews 18, 293–314.CrossRefGoogle ScholarPubMed
Metcalfe, T., Bowen, D. M. & Muller, D. P. R. (1989). Vitamin E concentrations in human brain of patients with Alzheimer's disease, fetuses with Down's syndrome, centenarians and controls. Neurochemical Research 14, 1209–1212.CrossRefGoogle ScholarPubMed
Mizuno, Y. & Ohta, K. (1986). Regional distribution of thiobarbituric acid-reactive products. activities of enzymes regulating the metabolism of oxygen free radicals, and some of the related enzymes in adult and aged rat brains. Journal of Neurochemistry 46, 1344–1352.CrossRefGoogle Scholar
Netter, K. J. (1986). Toxicodietetics: dietary alteration of toxic action. In New Concepts and Developments in Toxicology, pp. 139–144 [Chambers, P. L., Gehring, P. and Sakai, F., editors]. Amsterdam: Elsevier.Google Scholar
Nicklowitz, W. J. & Mandybur, T. I. (1975). Neurofibrillary changes following childhood lead encephalopathy. Journal of Neuropathology and Experimental Neurology 34, 445–455.CrossRefGoogle Scholar
Oteiza, P. I., Fraga, C. G. & Keen, C. L. (1993). Aluminum has both oxidant and antioxidant effects in mouse brain membranes. Archives of Biochemistry and Biophysics 300, 517–521.CrossRefGoogle ScholarPubMed
Parkinson Study Group (1993). Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease. New England Journal of Medicine 328, 176–183.CrossRefGoogle Scholar
Perl, D. P. & Good, P. F. (1987). Uptake of aluminium into central nervous system along nasal-olfactory pathways. Lancet i, 1028.CrossRefGoogle Scholar
Perry, T. L., Yong, V. W., Bergeron, C., Hansen, S. & Jones, K. (1987). Amino acids, glutathione, and glutathione transferase activity in the brains of patients with Alzheimer's disease. Annals of Neurology 21, 331–336.CrossRefGoogle ScholarPubMed
Petit, T. L., Alfano, D. P. & LeBoutillier, J. C. (1983). Early lead exposure and the hippocampus: a review and recent advances. Neurotoxicology 4, 79–94.Google ScholarPubMed
Powell, J. J. & Thompson, R. P. H. (1993). The chemistry of aluminium in the gastrointestinal lumen and its uptake and absorption. Proceedings of the Nutrition Society 52, 241–253.CrossRefGoogle ScholarPubMed
Prusiner, S. B. (1991). Molecular biology of prion diseases. Science 252, 1515–1522.CrossRefGoogle ScholarPubMed
Quartley, B., Esselmont, G., Taylor, A. & Dobrota, M. (1993). Effect of oral aluminium citrate on short-term tissue distribution of aluminium. Food and Chemical Toxicology 31, 543–548.CrossRefGoogle ScholarPubMed
Rifat, S. L. (1994). Aluminium hypothesis lives. Lancet 343, 3–4.CrossRefGoogle ScholarPubMed
Rifat, S. L., Eastwood, M. R., McLachlan, D. R. C. & Corey, P. N. (1990). Effect of exposure of miners to aluminium powder. Lancet 336, 1162–1165.CrossRefGoogle ScholarPubMed
Rogers, J., Kirby, L. C., Hempelman, S. R., Berry, D. L., McGeer, P. L., Kasniak, A. W., Zalinski, J., Cofield, M., Mansukhani, L., Willson, P. & Kogan, F. (1993). Clinical trial of indomethacin in Alzheimer's disease. Neurology 43, 1609–1611.CrossRefGoogle ScholarPubMed
Rosenberg, I. H. & Miller, J. W. (1992). Nutritional factors in physical and cognitive function of elderly people. American Journal of Clinical Nutrition 55, 1237S–1243S.CrossRefGoogle ScholarPubMed
Roskams, A. J. & Connor, J. R. (1990). Aluminum access to the brain: a role for transferrin and its receptor. Proceedings of National Academy of Sciences, USA 87, 9024–9027.CrossRefGoogle Scholar
Sachdev, P. (1993). The neuropsychiatry of brain iron. Journal of Neuropsychiatry and Clinical Neurosciences 5, 18–29.Google ScholarPubMed
Sakamoto, W., Fujie, K., Handa, H., Ogihara, T. & Mino, M. (1990). In vivo inhibition of superoxide production and protein kinase C activity in macrophages from vitamin E-treated rats. International Journal for Vitamin and Nutrition Research 60, 338–342.Google ScholarPubMed
Sato, P. H. & Hall, E. D. (1992). Tirilazad mesylate protects vitamins C and E in brain ischemia-reperfusion injury. Journal of Neurochemistry 58, 2263–2268.Google Scholar
Saunders, A. M., Strittmatter, W. J., Schmechel, D., St George-Hyslop, P. H., Pericak-Vance, M. A., Joo, S. H., Rosi, B. L., Cusella, J. F., McLachlan, D. R. C., Alberts, M. J., Hulette, C., Crain, B., Goldgaber, D. & Roses, A. D. (1993). Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43, 1467–1472.CrossRefGoogle Scholar
Sawada, M., Sester, U. & Carlson, J. C. (1992). Superoxide radical formation and associated biochemical alterations in the plasma membrane of brain, heart, and liver during the lifetime of the rat. Journal of Cellular Biochemistry 48, 296–304.CrossRefGoogle ScholarPubMed
SENECA (1991). Intake of vitamins and minerals. European Journal of Clinical Nutrition 45, 121–138.Google Scholar
Singhrao, S., Cole, G., Henderson, W. J. & Newman, G. R. (1990). LR white embedding allows a multi-method approach to the analysis of brain tissue from patients with Alzheimer's disease. Histochemical Journal 22, 257–268.CrossRefGoogle Scholar
Smith, C. D., Carney, J. M., Starke-Reed, P. E., Oliver, C. N., Stadtman, E. R., Floyd, R. A. & Markesbery, W. R. (1991). Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. Proceedings of National Academy of Sciences, USA 88, 10540–10543.CrossRefGoogle ScholarPubMed
Sokol, R. J. (1989). Vitamin E and neurologic function in man. Free Radical Biology & Medicine 6, 189–207.CrossRefGoogle ScholarPubMed
Sommer, B. R. & Wolkowitz, O. M. (1988). RBC folic acid levels and cognitive performance in elderly patients: a preliminary report. Biological Psychiatry 24, 352–354.CrossRefGoogle ScholarPubMed
Sonderer, B., Wild, P., Wyler, R., Fontana, A., Peterhans, E. & Schwyzer, M. (1987). Murine glia cells in culture can be stimulated to generate reactive oxygen. Journal of Leukocyte Biology 42, 463–473.CrossRefGoogle ScholarPubMed
Strittmatter, W. J., Weisgraber, K. H., Huang, D. Y., Dong, L.-M., Salveson, G. S., Pericak-Vance, M., Schmechel, D., Saunders, A. M., Goldgaber, D. & Roses, A. D. (1993). Binding of human apolipoprotein E to synthetic amyloid β peptide: isoform-specific effects and implications for late-onset Alzheimer's disease. Proceedings of National Academy of Sciences, USA 90, 8098–8102.CrossRefGoogle Scholar
Takashima, S., Kuruta, H., Mito, T., Houdou, S., Konomi, H., Yao, R. & Onodera, K. (1990). Immunochemistry of superoxide dismutase-1 in developing human brain. Brain Development 12, 211–213.CrossRefGoogle Scholar
Taylor, G. A., Ferrier, I. N., McLoughlin, I. J., Fairbairn, A. F., McKeith, I. G., Lett, D. & Edwardson, J. A. (1992). Gastrointestinal absorption of aluminium in Alzheimer's disease: response to aluminium citrate. Age and Ageing 21, 81–90.CrossRefGoogle ScholarPubMed
Théry, C., Chamak, B. & Mallat, M. (1991). Cytotoxic effect of brain macrophages on developing neurons. European Journal of Neuroscience 3, 1155–1164.CrossRefGoogle ScholarPubMed
Thompson, C. M., Markesbery, W. R., Ehmann, W. D., Mao, Y.-X. & Vance, D. E. (1988). Regional brain trace-element studies in Alzheimer's disease. Neurotoxicology 9, 1–8.Google ScholarPubMed
Van Rhijn, A. G., Prior, C. A. & Corrigan, F. M. (1990). Dietary supplementation with zinc sulphate, sodium selenite and fatty acids in early dementia of Alzheimer's type. Journal of Nutritional Medicine 1, 259–266.CrossRefGoogle Scholar
Ward, N. I. & Mason, J. A. (1987). Neutron activation analysis techniques for identifying elemental status in Alzheimer's disease. Journal of Radioanalytical and Nuclear Chemistry 113, 515–526.CrossRefGoogle Scholar
Wenk, G. L. & Stemmer, K. L. (1983). Suboptimal dietary zinc intake increases aluminum accumulation into the rat brain. Brain Research 288, 393–395.CrossRefGoogle ScholarPubMed
Wisniewski, H. M., Sturman, J. A. & Shek, J. W. (1982). Chronic model of neurofibrillary changes induced in mature rabbits by metallic aluminum. Neurobiology of Aging 3, 11–22.CrossRefGoogle ScholarPubMed
Yasui, M., Yase, Y., Ota, K. & Garruto, R. M. (1991). Evaluation of magnesium, calcium, and aluminum metabolism in rats and monkeys maintained on calcium-deficient diets. Neurotoxicology 12, 603–614.Google ScholarPubMed
Yue, T.-L., Barone, F. C., Gu, J.-L. & Feuerstein, G. Z. (1993). Brain α-tocopherol levels are not altered following ischemia/reperfusion-induced cerebral injury in rats and gerbils. Brain Research 610, 53–56.CrossRefGoogle Scholar
Zaman, Z., Roche, S., Fielden, P., Frost, P. G., Niriella, D. C. & Cayley, A. C. D. (1992). Plasma concentrations of vitamins A and E and carotenoids in Alzheimer's disease. Age and Ageing 21, 91–94.CrossRefGoogle Scholar
Zetzsche, T. & Chan-Palay, V. (1992). MAO A and B immunoreactivity in the hippocampus, temporal cortex and cerebellum of normal controls and of patients with senile dementia of the Alzheimer type. Dementia 3, 270–281.Google Scholar